These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

418 related items for PubMed ID: 17692739

  • 1. Cardiovascular protection using beta-blockers: a critical review of the evidence.
    Bangalore S, Messerli FH, Kostis JB, Pepine CJ.
    J Am Coll Cardiol; 2007 Aug 14; 50(7):563-72. PubMed ID: 17692739
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Why beta-blockers should not be used as first choice in uncomplicated hypertension.
    De Caterina AR, Leone AM.
    Am J Cardiol; 2010 May 15; 105(10):1433-8. PubMed ID: 20451690
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Beta-adrenergic antagonists in hypertension: a review of the evidence.
    Warmack TS, Estes MA, Heldenbrand S, Franks AM.
    Ann Pharmacother; 2009 Dec 15; 43(12):2031-43. PubMed ID: 19934392
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A meta-analysis of 94,492 patients with hypertension treated with beta blockers to determine the risk of new-onset diabetes mellitus.
    Bangalore S, Parkar S, Grossman E, Messerli FH.
    Am J Cardiol; 2007 Oct 15; 100(8):1254-62. PubMed ID: 17920367
    [Abstract] [Full Text] [Related]

  • 9. Cardioprotection with beta-blockers: myths, facts and Pascal's wager.
    Messerli FH, Bangalore S, Yao SS, Steinberg JS.
    J Intern Med; 2009 Sep 15; 266(3):232-41. PubMed ID: 19702791
    [Abstract] [Full Text] [Related]

  • 10. [Beta-blockers and arterial hypertension. Evidence-based medicine or excessive perseverance?].
    Verdecchia P, Angeli F, Achilli P, Castellani C, Repaci S, Ambrosio G.
    G Ital Cardiol (Rome); 2007 Sep 15; 8(9):552-8. PubMed ID: 17972424
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Are tolerability concerns a class effect of beta-blockers in treating patients with hypertension?
    Kountz DS.
    Postgrad Med; 2009 Jan 15; 121(1):14-24. PubMed ID: 19179810
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Do beta-blockers have a role in the modern treatment of arterial hypertension?].
    Horký K.
    Vnitr Lek; 1996 Jun 15; 42(6):420-5. PubMed ID: 8928415
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR.
    Clin Ther; 2007 Sep 15; 29(9):1803-24. PubMed ID: 18035185
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Beta-blockers in hypertensive and coronary heart disease.
    Goldstein S.
    Arch Intern Med; 1996 Jun 24; 156(12):1267-76. PubMed ID: 8651834
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.